Comparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5
Value Health
.
2014 Nov;17(7):A619.
doi: 10.1016/j.jval.2014.08.2189.
Epub 2014 Oct 26.
Authors
K Nersesyan
1
,
D Robinson
1
,
D Pomerantz
2
Affiliations
1
Kantar Health, St Louis, MO, USA.
2
Kantar Health, New York, NY, USA.
PMID:
27202174
DOI:
10.1016/j.jval.2014.08.2189
No abstract available